H.Res. 928 · 119th Congress

Affirming support for most-favored-Nation drug pricing for United States patients.

Stage
In committee
Introduced
2025-12-04
Latest action
2025-12-04 · Submitted in House

Action history

  1. 2025-12-04Submitted in House
  2. 2025-12-04Referred to the House Committee on Energy and Commerce.